Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Michael Bishop

Concepts (174)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Osteosarcoma
15
2024
44
4.420
Why?
Bone Neoplasms
17
2024
188
3.970
Why?
Sarcoma, Ewing
6
2024
32
1.830
Why?
Neuroblastoma
5
2021
55
1.360
Why?
Neoplasms
8
2025
1335
0.970
Why?
Antibodies, Monoclonal, Humanized
4
2021
238
0.960
Why?
Antineoplastic Combined Chemotherapy Protocols
7
2024
1043
0.880
Why?
Child, Preschool
19
2025
4164
0.820
Why?
Protein Kinase Inhibitors
2
2025
234
0.810
Why?
Induction Chemotherapy
4
2021
65
0.800
Why?
Child
27
2025
7384
0.790
Why?
Adolescent
26
2025
6912
0.790
Why?
Nuclear Proteins
2
2024
250
0.550
Why?
Young Adult
19
2023
4514
0.550
Why?
Male
29
2025
27444
0.470
Why?
Radionuclide Imaging
1
2016
107
0.470
Why?
Sarcoma
3
2024
72
0.460
Why?
Female
29
2025
28792
0.440
Why?
Retrospective Studies
15
2025
6821
0.440
Why?
Immunotherapy
2
2021
266
0.440
Why?
Molecular Targeted Therapy
1
2016
138
0.430
Why?
Desmoplastic Small Round Cell Tumor
3
2019
4
0.430
Why?
Hematopoietic Stem Cell Transplantation
1
2020
610
0.430
Why?
Lung Neoplasms
2
2020
645
0.420
Why?
Prognosis
7
2021
2118
0.420
Why?
Humans
39
2025
53246
0.410
Why?
Oncogene Proteins
1
2014
19
0.410
Why?
Adult
21
2022
14541
0.400
Why?
Adrenal Gland Neoplasms
1
2014
49
0.390
Why?
Survivors
4
2022
120
0.370
Why?
Bone and Bones
1
2016
501
0.360
Why?
Liver Neoplasms
2
2018
347
0.340
Why?
Granulocyte-Macrophage Colony-Stimulating Factor
2
2021
51
0.330
Why?
Neoplasm Recurrence, Local
5
2021
647
0.310
Why?
Infant
7
2025
3808
0.300
Why?
Peritoneal Neoplasms
3
2019
68
0.290
Why?
Hyperthermia, Induced
2
2019
114
0.260
Why?
Pain
2
2020
353
0.260
Why?
Cohort Studies
6
2020
1557
0.250
Why?
Cognition Disorders
2
2020
199
0.240
Why?
Methotrexate
2
2017
78
0.240
Why?
Follow-Up Studies
6
2021
2318
0.230
Why?
Combined Modality Therapy
4
2020
640
0.220
Why?
Survival Rate
4
2020
949
0.210
Why?
Wilms Tumor
1
2024
18
0.210
Why?
Rhabdoid Tumor
1
2024
13
0.210
Why?
Negative-Pressure Wound Therapy
1
2024
11
0.210
Why?
Treatment Outcome
7
2024
5597
0.200
Why?
Incidence
2
2025
1085
0.200
Why?
Neoadjuvant Therapy
1
2024
124
0.190
Why?
Kidney Neoplasms
1
2024
181
0.190
Why?
Risk Factors
6
2021
4018
0.190
Why?
DNA Helicases
1
2024
148
0.190
Why?
Chemotherapy, Adjuvant
3
2019
122
0.180
Why?
Echocardiography
1
2025
408
0.180
Why?
Prospective Studies
4
2021
2412
0.180
Why?
Interleukin-2
1
2021
69
0.170
Why?
Survival Analysis
2
2020
659
0.170
Why?
Transcription Factors
1
2024
571
0.160
Why?
Hypothyroidism
1
2021
58
0.160
Why?
Phthalazines
1
2020
20
0.160
Why?
Salvage Therapy
1
2021
138
0.160
Why?
Quality of Life
4
2021
902
0.160
Why?
Hypertension
1
2025
554
0.160
Why?
Central Nervous System Neoplasms
1
2021
69
0.160
Why?
Fluorodeoxyglucose F18
2
2023
182
0.150
Why?
Leydig Cells
1
2019
9
0.150
Why?
Leukemia, Myeloid, Acute
1
2021
208
0.150
Why?
Radiotherapy
2
2017
126
0.150
Why?
Brachytherapy
1
2019
51
0.140
Why?
Epigenomics
1
2019
76
0.140
Why?
Chemotherapy, Cancer, Regional Perfusion
1
2018
11
0.140
Why?
Alanine Transaminase
1
2018
118
0.140
Why?
Anesthetics
1
2018
38
0.140
Why?
Drug Resistance, Neoplasm
1
2021
350
0.140
Why?
Genetic Predisposition to Disease
2
2024
533
0.140
Why?
Transplantation, Autologous
1
2020
488
0.130
Why?
Chronic Disease
1
2020
581
0.130
Why?
Genomics
1
2019
271
0.130
Why?
Risk Assessment
5
2021
1368
0.130
Why?
Primary Ovarian Insufficiency
1
2017
4
0.130
Why?
Hand-Foot Syndrome
1
2017
1
0.130
Why?
Thoracic Wall
1
2017
8
0.130
Why?
Chile
1
2017
7
0.130
Why?
Thoracic Neoplasms
1
2017
12
0.130
Why?
Cytarabine
1
2017
44
0.130
Why?
Pain Management
1
2018
185
0.130
Why?
Cost of Illness
1
2017
121
0.130
Why?
Health Resources
1
2017
72
0.120
Why?
Karyotype
1
2016
22
0.120
Why?
Antimetabolites, Antineoplastic
1
2016
39
0.120
Why?
Radiation Injuries
1
2017
114
0.120
Why?
Hematologic Neoplasms
1
2017
101
0.120
Why?
Cell Line, Tumor
1
2020
1470
0.110
Why?
Urogenital Neoplasms
1
2015
9
0.110
Why?
Neurotoxicity Syndromes
1
2016
46
0.110
Why?
Proportional Hazards Models
1
2016
445
0.110
Why?
Forecasting
1
2015
152
0.110
Why?
Chromosome Aberrations
1
2016
297
0.100
Why?
Organ Sparing Treatments
1
2014
58
0.100
Why?
Disease Management
1
2015
187
0.100
Why?
Rats
1
2020
3164
0.100
Why?
Cross-Sectional Studies
4
2021
1723
0.100
Why?
Infant, Newborn, Diseases
1
2014
56
0.100
Why?
Cognition
1
2016
346
0.100
Why?
United States
3
2018
5413
0.090
Why?
Prevalence
3
2021
1034
0.090
Why?
Infant, Newborn
2
2017
2913
0.080
Why?
Neoplasm Staging
2
2023
774
0.070
Why?
Time Factors
3
2021
2992
0.070
Why?
Animals
2
2020
13528
0.070
Why?
Age Factors
2
2021
1136
0.060
Why?
Disease-Free Survival
2
2019
466
0.060
Why?
Middle Aged
5
2019
13422
0.060
Why?
Postoperative Complications
2
2024
1099
0.050
Why?
Databases, Factual
2
2018
742
0.050
Why?
Germ-Line Mutation
1
2024
67
0.050
Why?
Femoral Neoplasms
1
2024
8
0.050
Why?
Nephrectomy
1
2024
81
0.050
Why?
Limb Salvage
1
2024
43
0.050
Why?
Femur
1
2024
133
0.050
Why?
Surgical Wound Infection
1
2024
118
0.050
Why?
Radiopharmaceuticals
1
2023
198
0.050
Why?
Tumor Burden
1
2021
132
0.040
Why?
Positron-Emission Tomography
1
2023
299
0.040
Why?
Antineoplastic Agents
2
2020
1232
0.040
Why?
Ifosfamide
1
2021
9
0.040
Why?
Maximum Tolerated Dose
1
2021
42
0.040
Why?
Vincristine
1
2021
89
0.040
Why?
Tissue Distribution
1
2021
174
0.040
Why?
Length of Stay
1
2024
684
0.040
Why?
Gangliosides
1
2019
4
0.040
Why?
Luteinizing Hormone
1
2019
50
0.040
Why?
Anthracyclines
1
2020
35
0.040
Why?
Doxorubicin
1
2021
248
0.040
Why?
Testosterone
1
2019
142
0.040
Why?
Killer Cells, Natural
1
2019
113
0.040
Why?
Clinical Trials as Topic
1
2021
466
0.040
Why?
Radiotherapy, Adjuvant
1
2018
65
0.030
Why?
Kaplan-Meier Estimate
1
2019
487
0.030
Why?
Rare Diseases
1
2018
47
0.030
Why?
Epigenesis, Genetic
1
2021
412
0.030
Why?
Tumor Suppressor Protein p53
1
2019
228
0.030
Why?
Tennessee
1
2017
37
0.030
Why?
Parity
1
2017
46
0.030
Why?
Radiodermatitis
1
2017
5
0.030
Why?
Neoplasm, Residual
1
2018
171
0.030
Why?
Antineoplastic Agents, Alkylating
1
2017
78
0.030
Why?
Antibodies, Monoclonal
1
2021
477
0.030
Why?
Sex Distribution
1
2017
140
0.030
Why?
Ovary
1
2017
103
0.030
Why?
Age Distribution
1
2017
175
0.030
Why?
Proteomics
1
2019
337
0.030
Why?
Infusions, Intravenous
1
2017
211
0.030
Why?
Drug Administration Schedule
1
2017
370
0.030
Why?
Scoliosis
1
2017
63
0.030
Why?
Radiation Dosage
1
2017
160
0.030
Why?
Analysis of Variance
1
2017
547
0.030
Why?
Osteoporosis
1
2017
159
0.030
Why?
Multivariate Analysis
1
2017
598
0.030
Why?
Odds Ratio
1
2017
567
0.030
Why?
Memory
1
2016
98
0.030
Why?
Executive Function
1
2016
78
0.030
Why?
Attention
1
2016
169
0.030
Why?
Morbidity
1
2015
132
0.030
Why?
Extremities
1
2014
36
0.030
Why?
Emotions
1
2016
177
0.030
Why?
Body Mass Index
1
2017
717
0.030
Why?
Biopsy
1
2016
600
0.030
Why?
Dose-Response Relationship, Drug
1
2017
1367
0.030
Why?
Severity of Illness Index
1
2017
1049
0.020
Why?
Mutation
1
2019
1338
0.020
Why?
Case-Control Studies
1
2016
1212
0.020
Why?
Mice
1
2020
5982
0.020
Why?
Bishop's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description